News

An old drug supercharged by University of Queensland researchers has emerged as a new antibiotic that could destroy some of the world’s most dangerous superbugs.

Researchers have new insights into how protective antibodies attack dengue viruses, which could lead to more effective dengue fever vaccines and drug therapies.

The technicians who keep the research machinery running are among recipients of this year’s Institute for Molecular Bioscience (IMB) Impact Awards.

Improving the success rate of heart transplants is among the goals of a University of Queensland researcher, 50 years after the first such surgery was performed in South Africa.

A University of Queensland PhD student will spend 2018 undertaking research and training in sophisticated imaging techniques to better understand how promising Parkinson’s disease drugs enter the brain.

A new and improved version of the 'love hormone' oxytocin has been developed by University of Queensland researchers.

Changes to greatly improve the outcome, treatment and support for women with endometriosis have been the driving force for studies by a University of Queensland researcher.

Cancer biologist Dr Laura Genovesi is the recipient of a 2017 Early Career Fellowship to progress vital research into medulloblastoma, the most common type of malignant childhood brain cancer.

IMB and Cure Brain Cancer Foundation are partnering to overcome the scourge of paediatric brain tumours

Identification of a gene associated with motor neuron disease in people of Chinese ancestry will improve researchers understanding of the condition

Like Spiderman IRL, these clever arachnids pin down their prey with super-fast jets of liquid silk.

A small team in Brisbane are on the global antibiotic discovery map with their collaborative approach to fixing the antibiotic pipeline. They have become a benchmark network for researchers to join the antimicrobial resistance (AMR) field and advancing the AMR agenda in governments worldwide.

Discover how our bright minds and world-leading facilities combine to create solutions for health and environmental problems

IMB's Dr Lachlan Coin and Dr Luregn Schlapbach from the Lady Cilento Children's Hospital are fighting sepsis through developing better diagnostics

The revolution is coming.

Peptides are the new buzzword in medicine. But what's the difference between a peptide and a protein?

Meet the superbug of superbugs

Australian scientists have joined forces as part of a coordinated national approach to the Human Cell Atlas, an ambitious global initiative to create an ‘instruction manual for life itself.’

90 seconds with PhD student Emma Livingstone

If you could take a test that would reveal the diseases you and your family might be more likely to get, would you want to do it? Rapid developments in gene testing technologies have sparked debate about whether healthy Australians should undergo genetic testing.